Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

Related Keywords

United States ,Netherlands ,Holland ,America ,Robertg Shawah ,Davidp Luci , ,Paycheck Protection Program Loan ,Prnewswire Acurx Pharmaceuticals Inc ,Drug Administration ,Nasdaq ,Exchange Commission ,C Diff Foundation Conference ,Exchange Commission On Form ,Acurx Pharmaceuticals ,Anaerobe Society Of America ,Acurx Pharmaceuticals Inc ,Leiden University Medical Center Holland ,University Of Houston ,Leiden University Medical Center ,Anaerobe Society ,Antimicrobial Resistance Conference ,Diff Foundation Conference ,Chief Executive Officer ,Chief Financial Officer ,Gram Positive Selective Spectrum ,Qualified Infectious Disease Product ,Generating New Antibiotic Incentives Now ,Looking Statements ,Private Securities Litigation Reform Act ,Paycheck Protection Program ,Nc ,